Skip to main content

Table 4 Baseline characteristic of patients with Diabetes Mellitus

From: Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching

   Unmatched Propensity score matched
Characteristic Diabetic Cohort (n = 413) Inpatient Statin (n = 136) Non Statin (n = 277) p-value Inpatient Statin (n = 129) Non Statin (n = 129) p-value
Age, (years) n (%)
 Median (IQR) 66 (58–74) 66 (59.25–75) 66 (57–73) 0.48 66 (59–75) 68 (59.5–76) 0.36
 18–30 3 (0.7) 0 3 (1.1) 0 1 (0.8)
 31–45 27 (6.5) 4 (2.9) 23 (8.3) 3 (2.3) 11 (8.5)
 46–64 144 (34.9) 49 (36) 95 (34.3) 47 (36.4) 36 (27.9)
 ≥ 65 239 (57.9) 83 (61) 156 (56.3) 79 (61.2) 81 (62.8)
Sex, n (%)
 Male 217 (52.5) 68 (50) 149 (53.8) 0.47 64 (49.6) 63 (48.8) 0.9
 Female 196 (47.5) 68 (50) 128 (46.2) 65 (50.4) 66 (51.2)
Race, n (%)
 Blacks 314 (76) 101 (74.3) 213 (76.9) 0.56 97 (75.2) 97 (75.2) 1
 Other races 99 (24) 35 (25.7) 64 (23.1) 32 (24.8) 32 (24.8)
BMI
 Median (IQR) 29.8 (25.7–36.15) 29.95 (25.13–35.35) 29.8 (26.05–36.55) 0.65 30.3 (25.25–35.7) 30 (26.15–35.75) 0.79
 < 18.5 (underweight) 8 (1.9) 3 (2.2) 5 (1.8) 2 (1.6) 3 (2.3)
 18.5–24.9 (normal) 82 (19.9) 29 (21.3) 53 (19.1) 28 (21.7) 20 (15.5)
 25–29.9 (overweight) 118 (28.6) 36 (26.5) 82 (29.6) 33 (25.6) 40 (31)
 ≥ 30 (obese) 205 (49.6) 68 (50) 137 (49.5) 66 (51.2) 66 (51.2)
Comorbidities, n (%)
 Preexisting lung diseases 132 (32) 46 (33.8) 86 (31) 0.57 45 (34.9) 40 (31) 0.51
 Coronary artery disease 142 (34.4) 60 (44.1) 82 (29.6) 0.004 58 (45) 49 (38) 0.26
 Hypertension 378 (91.5) 130 (95.6) 248 (89.5) 0.04 123 (95.3) 117 (90.7) 0.14
 Hyperlipidemia 160 (38.7) 71 (52.2) 89 (32.1)  < 0.001 65 (50.4) 62 (48.1) 0.71
 Congestive Heart Failure 76 (18.4) 31 (22.8) 45 (16.2) 0.11 29 (22.5) 27 (20.9) 0.76
 Stroke 45 (10.9) 20 (14.7) 25 (9) 0.08 18 (14) 17 (13.2) 0.86
 Cancer 35 (8.5) 11 (8.1) 24 (8.7) 0.84 11 (8.5) 13 (10.1) 0.67
 Chronic liver disease 13 (3.1) 0 13 (4.7) 0.01 0 0  
 Chronic kidney disease 65 (15.7) 24 (17.6) 41 (14.8) 0.46 24 (18.6) 22 (17.1) 0.75
 ESRD on dialysis 53 (12.8) 18 (13.2) 35 (12.6) 0.86 18 (14) 14 (10.9) 0.45
 Smoking 176 (42.6) 62 (45.6) 114 (41.2) 0.39 59 (45.7) 61 (47.3) 0.8
Insurance
 Uninsured 7 (1.7) 3 (2.2) 4 (1.4) 0.5 3 (2.3) 3 (2.3) 0.77
 Medicaid 87 (21.1) 23 (16.9) 64 (23.1) 23 (17.8) 27 (20.9)
 Medicare 296 (71.7) 102 (75) 194 (70) 96 (74.4) 95 (73.6)
 Private 23 (5.6) 8 (5.9) 15 (5.4) 7 (5.4) 4 (3.1)
Days from symptom onset to hospital presentation
 0–5 289 (70) 95 (69.9) 194 (70) 0.26 92 (71.3) 96 (74.4) 0.36
 6–10 72 (17.4) 28 (20.6) 44 (15.9) 28 (21.7) 20 (15.5)
 11–15 25 (6.1) 5 93.7) 20 (7.2) 5 (3.9) 10 (7.8)
 16 +  8 (1.9) 4 (2.9) 4 (1.4) 4 (3.1) 3 (2.3)
CURB-65 at presentation
 0 77 (18.6) 18 (13.2) 59 (21.3) 0.21 17 (13.2) 18 (14) 0.8
 1 123 (29.8) 38 (27.9) 85 (30.7) 37 (28.7) 38 (29.5)
 2 145 (35.1) 58 (42.6) 87 (31.4) 56 (43.4) 48 (37.2)
 3 53 (12.8) 18 (13.2) 35 (12.6) 16 (12.4) 21 (16.3)
 4 8 (1.9) 3 (2.2) 5 (1.8) 3 (2.3) 3 (2.3)
 5 5 (1.2) 1 (0.7) 4 (1.4) 0 1 (0.8)